As Becton Dickinson (BDX) Market Valuation Rose, Gofen & Glossberg Increased Stake; Lagoda Investment Management LP Holding in Novo (NVO) Decreased as Shares Rose

Becton, Dickinson and Company (NYSE:BDX) Logo

Lagoda Investment Management Lp decreased its stake in Novo (NVO) by 98.99% based on its latest 2018Q4 regulatory filing with the SEC. Lagoda Investment Management Lp sold 333,265 shares as the company’s stock rose 6.98% with the market. The institutional investor held 3,405 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $157,000, down from 336,670 at the end of the previous reported quarter. Lagoda Investment Management Lp who had been investing in Novo for a number of months, seems to be less bullish one the $120.65 billion market cap company. The stock increased 0.83% or $0.42 during the last trading session, reaching $50.92. About 749,074 shares traded. Novo Nordisk A/S (NYSE:NVO) has declined 2.11% since March 15, 2018 and is downtrending. It has underperformed by 6.48% the S&P500. Some Historical NVO News: 26/03/2018 – NOVO: FDA APPROVED UPDATE TO TRESIBA PRESCRIBING INFORMATION; 23/05/2018 – EPIGEN IN PACT TO LICENSE LPA1 RECEPTOR PROGRAM TO NOVO NORDISK; 06/04/2018 – lmpax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%); 23/03/2018 – Novo Nordisk’s Saxenda Sales Rise; Obesity Market Up 4%; 27/03/2018 – Global Human Growth Hormone (hGH) Market Analysis & Outlook 2018-2022 with Profiles of Novartis, Pfizer, Eli Lilly and Co and Novo Nordisk – ResearchAndMarkets.com; 20/03/2018 – NOVO NORDISK NOVOb.CO – ADULTS WITH OBESITY TREATED WITH SEMAGLUTIDE LOST UP TO 13.8% OF THEIR BODY WEIGHT AFTER 52 WEEKS SIGNIFICANTLY MORE THAN THOSE TREATED WITH PLACEBO; 04/04/2018 – OMX Copenhagen 20 Falls 1.6% to 957.6; Novo Nordisk Leads Losses; 10/04/2018 – Tuberous Sclerosis Alliance salutes FDA approval of Afinitor® DISPERZ (everolimus) as the first adjunctive treatment approved in US for patients aged 2 years and older with tuberous sclerosis complex (TSC)-associated partial-onset seizures; 10/04/2018 – TUBEROUS SCLEROSIS ALLIANCE SALUTES FDA APPROVAL OF AFINITOR® DISPERZ (EVEROLIMUS) AS THE FIRST ADJUNCTIVE TREATMENT APPROVED IN US FOR PATIENTS AGED 2 YEARS AND OLDER WITH TUBEROUS SCLEROSIS COMPLEX…; 25/04/2018 – MYLAN NV – U.S. LAUNCH OF DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP, 3 MG/0.02 MG, A GENERIC VERSION OF BAYER’S YAZ TABLETS

Gofen & Glossberg Llc increased its stake in Becton Dickinson (BDX) by 5.52% based on its latest 2018Q4 regulatory filing with the SEC. Gofen & Glossberg Llc bought 2,261 shares as the company’s stock rose 1.29% with the market. The institutional investor held 43,228 shares of the health care company at the end of 2018Q4, valued at $9.74 million, up from 40,967 at the end of the previous reported quarter. Gofen & Glossberg Llc who had been investing in Becton Dickinson for a number of months, seems to be bullish on the $68.39B market cap company. The stock increased 0.76% or $1.91 during the last trading session, reaching $254.17. About 1.14M shares traded or 5.42% up from the average. Becton, Dickinson and Company (NYSE:BDX) has risen 15.93% since March 15, 2018 and is uptrending. It has outperformed by 11.56% the S&P500. Some Historical BDX News: 23/03/2018 – FDA: Becton Dickinson (BD) and Company Recalls Vacutainer® EDTA Blood Collection Tubes Due to Chemical Interference with; 19/04/2018 – BD Unveils Suite of Diagnostic Informatics and Automation Innovations; 22/03/2018 – U.S FDA PROVIDES STATEMENT ON FINDINGS FROM ONGOING INVESTIGATION INTO LEAD TESTING ISSUES; 03/05/2018 – Becton Dickinson 2Q Rev $4.22B; 26/04/2018 – BD Launches BD FACSymphony™ S6 High Parameter Cell Sorter to Enable Sorting of Rare Cell Types; 03/05/2018 – Becton Dickinson Raises FY18 Rev Growth View to 31%-31.5%; 09/03/2018 FDA: Becton Dickinson & Co.- Difco” Agar Noble, 500g bottle Noble Agar is a solidifying agent that is essentially free of; 12/03/2018 – FDA: Becton Dickinson & Company- BD Vacutainer® K2 EDTA (K2E) 3.6mg Blood Collection Tube (13 x 75 mm x 2.0 mL). Catalog Numbe; 22/03/2018 – U.S FDA SAYS CONTINUES TO RECOMMEND THAT MAGELLAN LEAD TESTS NOT BE USED WITH BLOOD SAMPLES TAKEN FROM THE VEIN; 15/05/2018 – SANDELL EXITED BDX IN 1Q: 13F

More important recent Novo Nordisk A/S (NYSE:NVO) news were published by: Streetinsider.com which released: “Novo Nordisk (NVO) receives US FDA approval of ESPEROCT – StreetInsider.com” on February 19, 2019, also Seekingalpha.com published article titled: “Novo Nordisk files for label expansion for insulin Fiasp – Seeking Alpha”, Seekingalpha.com published: “Lilly to launch lower-priced insulin in U.S. – Seeking Alpha” on March 04, 2019. More interesting news about Novo Nordisk A/S (NYSE:NVO) was released by: Seekingalpha.com and their article: “Novo Nordisk Has Managed The Turnaround – Seeking Alpha” with publication date: February 13, 2019.

Analysts await Novo Nordisk A/S (NYSE:NVO) to report earnings on May, 1. They expect $0.63 EPS, down 13.70% or $0.10 from last year’s $0.73 per share. NVO’s profit will be $1.49B for 20.21 P/E if the $0.63 EPS becomes a reality. After $0.54 actual EPS reported by Novo Nordisk A/S for the previous quarter, Wall Street now forecasts 16.67% EPS growth.

Lagoda Investment Management Lp, which manages about $725.00 million and $59.96M US Long portfolio, upped its stake in Xpo Logistics Inc (NYSE:XPO) by 17,544 shares to 80,092 shares, valued at $4.57M in 2018Q4, according to the filing.

More notable recent Becton, Dickinson and Company (NYSE:BDX) news were published by: Seekingalpha.com which released: “Becton, Dickinson beats by $0.08, beats on revenue – Seeking Alpha” on February 05, 2019, also Seekingalpha.com with their article: “Consider Becton, Dickinson As Bard Deal Drives Value – Seeking Alpha” published on January 14, 2019, Seekingalpha.com published: “Becton, Dickinson sees FQ1 revenues as high as $4.2B – Seeking Alpha” on January 17, 2019. More interesting news about Becton, Dickinson and Company (NYSE:BDX) were released by: Seekingalpha.com and their article: “FDA OK’s BD’s Venovo stent – Seeking Alpha” published on March 14, 2019 as well as Seekingalpha.com‘s news article titled: “Becton, Dickinson Q1 2019 Earnings Preview – Seeking Alpha” with publication date: February 04, 2019.

Gofen & Glossberg Llc, which manages about $3.51B and $2.53 billion US Long portfolio, decreased its stake in Schlumberger Ltd (NYSE:SLB) by 65,829 shares to 457,332 shares, valued at $16.50M in 2018Q4, according to the filing. It also reduced its holding in At&T (NYSE:T) by 17,246 shares in the quarter, leaving it with 304,649 shares, and cut its stake in Chubb Ltd.

Since November 7, 2018, it had 0 insider buys, and 7 sales for $18.75 million activity. On Thursday, November 8 the insider Lim James C sold $1.26 million. 4,530 shares were sold by Mas Ribo Alberto, worth $1.07M. 42,000 shares were sold by RING TIMOTHY M, worth $9.96 million. Borzi James W also sold $1.49M worth of Becton, Dickinson and Company (NYSE:BDX) shares. FORLENZA VINCENT A sold $3.18 million worth of Becton, Dickinson and Company (NYSE:BDX) on Wednesday, November 14. $511,328 worth of Becton, Dickinson and Company (NYSE:BDX) was sold by Bodner Charles R on Friday, November 16.

Investors sentiment increased to 0.91 in Q4 2018. Its up 0.01, from 0.9 in 2018Q3. It increased, as 64 investors sold BDX shares while 391 reduced holdings. 98 funds opened positions while 315 raised stakes. 226.22 million shares or 4.12% more from 217.26 million shares in 2018Q3 were reported. 22,816 were accumulated by New Mexico Educational Retirement Board. Confluence Invest Management Ltd holds 0.39% of its portfolio in Becton, Dickinson and Company (NYSE:BDX) for 91,425 shares. Whittier Tru Of Nevada owns 0.09% invested in Becton, Dickinson and Company (NYSE:BDX) for 4,958 shares. Buffington Mohr Mcneal has invested 1.87% in Becton, Dickinson and Company (NYSE:BDX). 13,581 are held by Delta Management Ltd Co. Auxier Asset Management holds 1.06% in Becton, Dickinson and Company (NYSE:BDX) or 21,025 shares. 37,820 are held by Mason Street Advsr Limited Liability Co. The Texas-based Tctc Hldg Ltd Limited Liability Company has invested 0.02% in Becton, Dickinson and Company (NYSE:BDX). Lenox Wealth reported 467 shares. 25,986 are owned by Sky Group. 11,125 are owned by B & T Mgmt Dba Alpha Mgmt. Connors Investor Inc invested in 1.34% or 38,048 shares. Dillon Associates has invested 0.18% in Becton, Dickinson and Company (NYSE:BDX). Garde Capital Inc, Washington-based fund reported 5,200 shares. Zurcher Kantonalbank (Zurich Cantonalbank) has 99,553 shares.

Becton, Dickinson and Company (NYSE:BDX) Institutional Positions Chart